Curcumin‐coated gold nanoparticles attenuate doxorubicin‐induced cardiotoxicity via regulating apoptosis in a mouse model. (7th September 2021)
- Record Type:
- Journal Article
- Title:
- Curcumin‐coated gold nanoparticles attenuate doxorubicin‐induced cardiotoxicity via regulating apoptosis in a mouse model. (7th September 2021)
- Main Title:
- Curcumin‐coated gold nanoparticles attenuate doxorubicin‐induced cardiotoxicity via regulating apoptosis in a mouse model
- Authors:
- Sharifiaghdam, Zeynab
Dalouchi, Fereshteh
Sharifiaghdam, Maryam
Shaabani, Elnaz
Ramezani, Fatemeh
Nikbakht, Farnaz
Azizi, Yaser - Abstract:
- Abstract: Doxorubicin (DOX) is one of the most widely used chemotherapy agents; however, its nonselective effect causes cardiotoxicity. Curcumin (Cur), a well known dietary polyphenol, could exert a significant cardioprotective effect, but the biological application of this substance is limited by its chemical insolubility. To overcome this limitation, in this study, we synthesised gold nanoparticles based on Cur (Cur‐AuNPs). Ultraviolet‐visible (UV‐Vis) absorbance spectroscopy and transmission electron microscopy (TEM) were performed for the characterisation of synthesised NPs, and Fourier transform infrared (FTIR) spectroscopy were applied to detect Cur on the surface of AuNPs. Its cytotoxicity effect on H9c2 cells was evaluated using 3‐(4, 5‐dimethylthiazol‐2‐yl)‐2, 5‐diphenyltetrazolium bromide (MTT) assay. The biological efficacy of Cur‐AuNPs was assessed after acute cardiotoxicity induction in BALB/c mice with DOX injection. The serum biomarkers, myocardial histological changes, and cardiomyocyte apoptosis were then measured. The results revealed that the heart protection by Cur‐AuNPs is more effective than Cur alone. Heart protective effect of Cur‐AuNPs was evident both in the short‐term (24 hours) and long‐term (14 days) study. The results of Cur‐AuNPs400 after 24 hours of toxicity induction displayed the reduction of the cardiac injury serum biomarkers (LDH, CK‐MB, cTnI, ADT, and ALT) and apoptotic proteins (Bax and Caspase‐3), as well as increase of Bcl‐2Abstract: Doxorubicin (DOX) is one of the most widely used chemotherapy agents; however, its nonselective effect causes cardiotoxicity. Curcumin (Cur), a well known dietary polyphenol, could exert a significant cardioprotective effect, but the biological application of this substance is limited by its chemical insolubility. To overcome this limitation, in this study, we synthesised gold nanoparticles based on Cur (Cur‐AuNPs). Ultraviolet‐visible (UV‐Vis) absorbance spectroscopy and transmission electron microscopy (TEM) were performed for the characterisation of synthesised NPs, and Fourier transform infrared (FTIR) spectroscopy were applied to detect Cur on the surface of AuNPs. Its cytotoxicity effect on H9c2 cells was evaluated using 3‐(4, 5‐dimethylthiazol‐2‐yl)‐2, 5‐diphenyltetrazolium bromide (MTT) assay. The biological efficacy of Cur‐AuNPs was assessed after acute cardiotoxicity induction in BALB/c mice with DOX injection. The serum biomarkers, myocardial histological changes, and cardiomyocyte apoptosis were then measured. The results revealed that the heart protection by Cur‐AuNPs is more effective than Cur alone. Heart protective effect of Cur‐AuNPs was evident both in the short‐term (24 hours) and long‐term (14 days) study. The results of Cur‐AuNPs400 after 24 hours of toxicity induction displayed the reduction of the cardiac injury serum biomarkers (LDH, CK‐MB, cTnI, ADT, and ALT) and apoptotic proteins (Bax and Caspase‐3), as well as increase of Bcl‐2 anti‐apoptotic proteins without any sign of interfibrillar haemorrhage and intercellular spaces in the heart tissue microscopic images. Our long‐term study signifies that Cur‐AuNPs400 in DOX‐intoxicated mice could successfully inhibit body and heart weight loss in comparison to DOX group. Abstract : … (more)
- Is Part Of:
- Clinical and experimental pharmacology and physiology. Volume 49:Number 1(2022)
- Journal:
- Clinical and experimental pharmacology and physiology
- Issue:
- Volume 49:Number 1(2022)
- Issue Display:
- Volume 49, Issue 1 (2022)
- Year:
- 2022
- Volume:
- 49
- Issue:
- 1
- Issue Sort Value:
- 2022-0049-0001-0000
- Page Start:
- 70
- Page End:
- 83
- Publication Date:
- 2021-09-07
- Subjects:
- apoptosis -- cardiotoxicity -- curcumin -- doxorubicin -- gold nanoparticles
Clinical pharmacology -- Periodicals
Pharmacology, Experimental -- Periodicals
Physiology, Experimental -- Periodicals
Physiology, Pathological -- Periodicals
615.1 - Journal URLs:
- http://www.blackwell-synergy.com/member/institutions/issuelist.asp?journal=cep ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/1440-1681.13579 ↗
- Languages:
- English
- ISSNs:
- 0305-1870
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3286.252000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 20223.xml